Changes in the antiangiogenic properties of articular cartilage in osteoarthritis

Avascularity is important for the unique biomechanical properties of articular cartilage, and normal cartilage actively repels vascular invasion. This study investigated whether the antiangiogenic properties changed in the presence of osteoarthritis (OA) by culturing explants of human articular cartilage on the chorioallantoic membrane (CAM) of chick embryos and investigating the incidence of vascular invasion and the effects of exogenous vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9). The results were compared with those of non-OA cartilage obtained after femoral neck fractures. Altogether, 72% of OA samples but only 5% of non-OA samples were invaded by the CAM, indicating that changes in the antiangiogenic properties represented a fundamental difference between control and OA cartilage. Exogenous VEGF or MMP-9 increased the frequency of invasion to 70%–100%. Invasion most frequently occurred into cartilage matrix from which proteoglycans had been lost, the latter being detectable by sirius red staining of cartilage collagen. VEGF was synthesized by chondrocytes in proportion to the severity of degradation and might exacerbate the loss of resistance to invasion. These results indicate that loss of resistance to vascular invasion distinguishes OA cartilage from normal articular cartilage, which may be important in the pathogenesis of OA.

[1]  T. Aigner,et al.  Molecular pathology and pathobiology of osteoarthritic cartilage , 2002, Cellular and Molecular Life Sciences CMLS.

[2]  L. Junqueira,et al.  Quantitation of collagen - proteoglycan interaction in tissue sections. , 1980, Connective tissue research.

[3]  A. Harris,et al.  The angiogenic pathway ‘vascular endothelial growth factor/flk‐1(KDR)‐receptor’ in rheumatoid arthritis and osteoarthritis , 2001, The Journal of pathology.

[4]  P. Gregg,et al.  Osteoarthritic cartilage loses its ability to remain avascular. , 1999, Osteoarthritis and cartilage.

[5]  Y. Sasaguri,et al.  Matrix metalloproteinases in patients with osteoarthritis of the hip , 2000, International Orthopaedics.

[6]  S. Stacker,et al.  The vascular endothelial growth factor family; proteins which guide the development of the vasculature , 1998, International journal of experimental pathology.

[7]  H. Roach,et al.  Histological abnormalities of the calcaneum in congenital talipes equinovarus , 2001, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[8]  A. Freemont,et al.  Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific , 1997, Annals of the rheumatic diseases.

[9]  R. Brentani,et al.  Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections , 1979, The Histochemical Journal.

[10]  N. Ferrara,et al.  Angiogenesis and bone growth. , 2000, Trends in cardiovascular medicine.

[11]  H. Roach,et al.  Initiation of the Bony Epiphysis in Long Bones: Chronology of Interactions Between the Vascular System and the Chondrocytes , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  W. Maloney,et al.  RT-PCR analysis of MMP-9 expression in human articular cartilage chondrocytes and synovial fluid cells. , 1996, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[13]  C. P. Leblond,et al.  Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats ages 0–21 days: I. Two groups of proteinases cleave the core protein of aggrecan , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.

[14]  D. Woolley,et al.  Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. , 2001, Arthritis and rheumatism.

[15]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[16]  H. Dorfman,et al.  Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. , 1971, The Journal of bone and joint surgery. American volume.

[17]  J. Winer,et al.  The vascular endothelial growth factor family of polypeptides , 1991, Journal of cellular biochemistry.

[18]  Napoleone Ferrara,et al.  VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation , 1999, Nature Medicine.

[19]  N. Sorgente,et al.  The resistance of certain tissues to invasion: penetrability of explanted tissues by vascularized mesenchyme. , 1973, The American journal of pathology.

[20]  R. Cancedda,et al.  Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. , 2000, Journal of cell science.

[21]  H. Roach,et al.  Physiological cell death of chondrocytes in vivo is not confined to apoptosis. New observations on the mammalian growth plate. , 2000, The Journal of bone and joint surgery. British volume.

[22]  T. Pufe,et al.  The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. , 2001, Arthritis and rheumatism.

[23]  P H Burri,et al.  Chorioallantoic membrane capillary bed: A useful target for studying angiogenesis and anti‐angiogenesis in vivo , 2001, The Anatomical record.

[24]  R. Brown,et al.  Neovascularisation and its role in the osteoarthritic process. , 1988, Annals of the rheumatic diseases.

[25]  J TRUETA,et al.  Osteoarthritis of the hip: a study of the nature and evolution of the disease. , 1953, The Journal of bone and joint surgery. British volume.

[26]  J. Pelletier,et al.  Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[27]  F. Lafeber,et al.  Osteoarthritic human cartilage is more sensitive to transforming growth factor beta than is normal cartilage. , 1993, British journal of rheumatology.

[28]  Gabriele Bergers,et al.  MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.

[29]  H. Mankin,et al.  Biochemical and metabolic abnormalities in normal and osteoarthritic human articular cartilage. , 1984, Arthritis and rheumatism.